Engineering-inspired approaches to study β-cell function and diabetes.

Area of Science:

• Biomedical Engineering
• Endocrinology
• Cell Biology

Background:

• Diabetes mellitus is a complex metabolic disorder characterized by hyperglycemia, necessitating improved therapeutic strategies.
• Understanding pancreatic beta-cell (β-cell) physiology is critical for developing effective diabetes treatments.
• Current therapeutic approaches range from insulin administration to complex drug regimens and lifestyle modifications.

Purpose of the Study:

• To review current research models for studying β-cell biology in the context of diabetes.
• To discuss the application of engineered platforms and organ-on-a-chip systems for β-cell research.
• To highlight the potential of these advanced systems for developing novel diabetes therapeutics.

Main Methods:

• Review of existing literature on β-cell research models, including primary cells, cell lines, and stem cell-derived β-like cells.
• Discussion of engineered platforms and organ-on-a-chip technologies for mimicking in vivo β-cell microenvironments.
• Exploration of high-throughput screening strategies for β-cell research.

Main Results:

• Various cell sources (primary, cell lines, stem cell-derived) offer distinct advantages and disadvantages for β-cell research.
• Engineered platforms and organ-on-a-chip models increasingly replicate in vivo conditions, including inter-organ interactions.
• High-throughput methods significantly contribute to understanding β-cell function and developing new therapies.

Conclusions:

• Advanced experimental systems, particularly engineered platforms and organ-on-a-chip models, are crucial for dissecting β-cell biology and pathogenesis.
• Studying β-cell interactions with other endocrine organs in engineered systems holds promise for novel diabetes therapeutics.
• These innovative approaches are vital for translating research findings into clinical applications for diabetes treatment.